Thiazole, thio and semicarbazone derivatives against tropical infective diseases: Chagas disease, human African trypanosomiasis (HAT), leishmaniasis, and malaria

Eur J Med Chem. 2019 Jan 15:162:378-395. doi: 10.1016/j.ejmech.2018.11.013. Epub 2018 Nov 12.

Abstract

Thiazole, thiosemicarbazone and semicarbazone moieties are privileged scaffolds (acting as primary pharmacophores) in many compounds that are useful to treat several diseases, mainly tropical infectious diseases. In this review article, we critically analyzed the contribution of these scaffolds to medicinal chemistry in the last five years, focusing on tropical infectious diseases, such as Chagas disease, human African trypanosomiasis (HAT), leishmaniasis, and malaria. We also present perspectives for their use in drug design in order to contribute to the development of new drugs.

Keywords: Chagas disease; Drug development; New drugs; Semicarbazone; T. cruzi; Thiazole; Thiosemicarbazone.

Publication types

  • Review

MeSH terms

  • Animals
  • Chagas Disease / drug therapy
  • Drug Design
  • Humans
  • Leishmaniasis / drug therapy
  • Malaria / drug therapy
  • Protozoan Infections / drug therapy*
  • Semicarbazones / therapeutic use*
  • Thiazoles / therapeutic use*
  • Thiosemicarbazones / therapeutic use*
  • Trypanosomiasis, African / drug therapy

Substances

  • Semicarbazones
  • Thiazoles
  • Thiosemicarbazones